✦ LIBER ✦

Expression of urokinase-type plasminogen activator system in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy

✍ Scribed by Masafumi Kumano; Hideaki Miyake; Mototsugu Muramaki; Junya Furukawa; Atsushi Takenaka; Masato Fujisawa

Book ID: 116956267
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 960 KB
Volume: 27
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2008.01.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of potential molecular marker

Expression of potential molecular markers in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy

✍ Hideaki Miyake; Mototsugu Muramaki; Toshifumi Kurahashi; Atsushi Takenaka; Masat 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 334 KB

Expression of clusterin in prostate canc

Expression of clusterin in prostate cancer correlates with gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy

✍ Hideaki Miyake; Mototsugu Muramaki; Toshifumi Kurahashi; Kazuki Yamanaka; Isao H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Association of plasma urokinase-type pla

Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder

✍ Shahrokh F Shariat; Mara A Monoski; Ben Andrews; Thomas M Wheeler; Seth P Lerner 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Urokinase-plasminogen-activator receptor

Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer

✍ Christian Thomas; Christoph Wiesner; Sebastian W. Melchior; Folke Schmidt; Rolf 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Elevation of serum levels of urokinase-t

Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

✍ Miyake, Hideaki; Hara, Isao; Yamanaka, Kazuki; Gohji, Kazuo; Arakawa, Soichi; Ka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a

Persistent expression of Aurora-A after

Persistent expression of Aurora-A after neoadjuvant hormonal therapy as a predictor of a poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer

✍ Junya Furukawa; Hideaki Miyake; Atsushi Takenaka; Isao Hara; Masato Fujisawa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB